← All trials
NCT04742491
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 21, 2021
- Primary completion
- Mar 21, 2024
- Completion date
- Nov 21, 2024
- First posted
- Feb 8, 2021
- Last posted
- Jun 14, 2021
- Enrollment
- 310
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- HIV Prevention Trials NetworkLead sponsor
- University of North Carolina at Chapel HillStudy chair
- Gilead SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.